Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models – PubMed Black Hawk Supplements
BLACK HAWK: High quality lions mane supplement for
Published article
Botanicals contain complex mixtures of chemicals most of which lack pharmacokinetic data in humans. Since physicochemical and pharmacokinetic properties dictate the in vivo exposure of botanical constituents, these parameters greatly impact the pharmacological and toxicological effects of botanicals in consumer products. This study sought to use computational (i.e., in silico) models, including quantitative structure-activity relationships (QSAR) and physiologically based pharmacokinetic (PBPK)…
Black Hawk Supplements, best supplements in the UK
Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
Yitong Liu et al. J Appl Toxicol. .
Abstract
Botanicals contain complex mixtures of chemicals most of which lack pharmacokinetic data in humans. Since physicochemical and pharmacokinetic properties dictate the in vivo exposure of botanical constituents, these parameters greatly impact the pharmacological and toxicological effects of botanicals in consumer products. This study sought to use computational (i.e., in silico) models, including quantitative structure-activity relationships (QSAR) and physiologically based pharmacokinetic (PBPK) modeling, to predict properties of botanical constituents. One hundred and three major constituents (e.g., withanolides, mitragynine, and yohimbine) in 13 botanicals (e.g., ashwagandha, kratom, and yohimbe) were investigated. The predicted properties included biopharmaceutical classification system (BCS) classes based on aqueous solubility and permeability, oral absorption, liver microsomal clearance, oral bioavailability, and others. Over half of these constituents fell into BCS classes I and II at dose levels no greater than 100 mg per day, indicating high permeability and absorption (%Fa > 75%) in the gastrointestinal tract. However, some constituents such as glycosides in ashwagandha and Asian ginseng showed low bioavailability after oral administration due to poor absorption (BCS classes III and IV, %Fa < 40%). These in silico results fill data gaps for botanical constituents and could guide future safety studies. For example, the predicted human plasma concentrations may help select concentrations for in vitro toxicity testing. Additionally, the in silico data could be used in tiered or batteries of assays to assess the safety of botanical products. For example, highly absorbed botanical constituents indicate potential high exposure in the body, which could lead to toxic effects.
Keywords: Botanical Safety Consortium; PBPK; QSAR; biopharmaceutical classification system; botanical; computational modeling; constituent; in silico; pharmacokinetics.
© 2024 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.
Similar articles
-
Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C. Sjögren E, et al. Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29. Eur J Pharm Sci. 2013. PMID: 23727464
-
Pettarin M, Bolger MB, Chronowska M, Kostewicz ES. Pettarin M, et al. Eur J Pharm Sci. 2020 Dec 1;155:105552. doi: 10.1016/j.ejps.2020.105552. Epub 2020 Sep 13. Eur J Pharm Sci. 2020. PMID: 32937212
-
Markovic M, Zur M, Ragatsky I, Cvijić S, Dahan A. Markovic M, et al. Pharmaceutics. 2020 Dec 2;12(12):1175. doi: 10.3390/pharmaceutics12121175. Pharmaceutics. 2020. PMID: 33276565 Free PMC article.
-
PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, Jamei M, Lloyd R, Pepin X, Rostami-Hodjegan A, Sjögren E, Tannergren C, Turner DB, Wagner C, Weitschies W, Dressman J. Kostewicz ES, et al. Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21. Eur J Pharm Sci. 2014. PMID: 24060672 Review.
-
EFSA GMO Panel Working Group on Animal Feeding Trials. EFSA GMO Panel Working Group on Animal Feeding Trials. Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
References
REFERENCES
-
- Alqahtani, S. (2017). In silico ADME‐Tox modeling: Progress and prospects. Expert Opinion on Drug Metabolism & Toxicology, 13(11), 1147–1158. https://doi.org/10.1080/17425255.2017.1389897
-
- Amidon, G. L., Lennernas, H., Shah, V. P., & Crison, J. R. (1995). A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12(3), 413–420. https://doi.org/10.1023/a:1016212804288
-
- Andreu‐Fernandez, V., Almeida Toledano, L., Pizarro, N., Navarro‐Tapia, E., Gomez‐Roig, M. D., de la Torre, R., & Garcia‐Algar, O. (2020). Bioavailability of epigallocatechin gallate administered with different nutritional strategies in healthy volunteers. Antioxidants (Basel), 9(5). https://doi.org/10.3390/antiox9050440
-
- Bell, S. M., Chang, X., Wambaugh, J. F., Allen, D. G., Bartels, M., Brouwer, K. L. R., Casey, W. M., Choksi, N., Ferguson, S. S., Fraczkiewicz, G., Jarabek, A. M., Ke, A., Lumen, A., Lynn, S. G., Paini, A., Price, P. S., Ring, C., Simon, T. W., Sipes, N. S., … Kleinstreuer, N. C. (2018). In vitro to in vivo extrapolation for high throughput prioritization and decision making. Toxicology in Vitro, 47, 213–227. https://doi.org/10.1016/j.tiv.2017.11.016
-
- Ghosh, J., Lawless, M. S., Waldman, M., Gombar, V., & Fraczkiewicz, R. (2016). Modeling ADMET. Methods in Molecular Biology, 1425, 63–83. https://doi.org/10.1007/978-1-4939-3609-0_4
LinkOut – more resources
-
Full Text Sources
BLACK HAWK: Best shilajit supplement for women
Read the original publication: